What is a stock summary page? Click here for an overview.
Business Description
4d pharma PLC
ISIN : GB00BJL5BR07
Compare
Compare
Traded in other countries / regions
4DY.GermanyDDDD.UK IPO Date
2014-02-18Description
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -48.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -4843.87 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
4d pharma PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 0.522 | ||
| EPS (TTM) (£) | -0.319 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.22 | ||
| 3-Year Sortino Ratio | 0.53 | ||
| Volatility % | 74.19 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (£) | - | ||
| 20-Day SMA (£) | - | ||
| 12-1 Month Momentum % | -48.26 | ||
| 52-Week Range (£) | 0.136 - 0.77 | ||
| Shares Outstanding (Mil) | 180.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
4d pharma PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
4d pharma PLC Stock Events
| Event | Date | Price (£) | ||
|---|---|---|---|---|
| No Event Data | ||||
4d pharma PLC Frequently Asked Questions
What is 4d pharma PLC(LSE:DDDD)'s stock price today?
The current price of LSE:DDDD is £0.17. The 52 week high of LSE:DDDD is £0.77 and 52 week low is £0.14.
When is next earnings date of 4d pharma PLC(LSE:DDDD)?
The next earnings date of 4d pharma PLC(LSE:DDDD) is 2025-04-25 Est..
Does 4d pharma PLC(LSE:DDDD) pay dividends? If so, how much?
4d pharma PLC(LSE:DDDD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers